PPAR-γ is upregulated in the liver of obese patients with NAFLD, representing an additional reinforcing lipogenic mechanism to sterol regulatory element-binding protein 1c (SREBP-1c) induction in the development of hepatic steatosis [53]. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatotic liver disease.